Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methylpropylpropanediol dinitrate is an organic nitrate compound belonging to the class of alkyl nitrates. It is structurally related to other organic nitrates used as vasodilators in cardiovascular therapy. Like other compounds in this class, it acts as a nitric oxide donor, leading to vasodilation by relaxing vascular smooth muscle. This mechanism underlies its use for the treatment and prevention of angina pectoris and potentially other ischemic heart conditions[1][4][9]. The compound has a molecular formula of C7H14N2O6 and a molecular weight of approximately 222.20 g/mol[6]. Its pharmacological effects are presumed similar to those of other organic nitrates such as nitroglycerin and isosorbide dinitrate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylpropylpropanediol dinitrate.